Milestone Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Protagenic Therapeutics (NASDAQ:PTIX – Get Free Report) and Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation. Analyst Recommendations This is a breakdown of […]

Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Free Report) – Investment analysts at HC Wainwright dropped their FY2025 earnings per share (EPS) estimates for shares of Milestone Pharmaceuticals in a research report issued to clients and investors on Monday, August 14th. HC Wainwright analyst P. Trucchio now expects that the company will earn $0.05 per share for […]

Alaunos Therapeutics (NASDAQ:TCRT – Get Rating) and Milestone Pharmaceuticals (NASDAQ:MIST – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation. Analyst Ratings This is a breakdown of current recommendations […]

Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Rating) – Research analysts at Oppenheimer issued their Q1 2023 earnings per share (EPS) estimates for Milestone Pharmaceuticals in a report released on Wednesday, April 12th. Oppenheimer analyst L. Gershell expects that the company will post earnings of ($0.38) per share for the quarter. Oppenheimer has a “Outperform” rating […]

HC Wainwright restated their buy rating on shares of Milestone Pharmaceuticals (NASDAQ:MIST – Get Rating) in a research report sent to investors on Thursday, Benzinga reports. HC Wainwright currently has a $25.00 target price on the stock. HC Wainwright also issued estimates for Milestone Pharmaceuticals’ FY2026 earnings at $1.07 EPS and FY2027 earnings at $2.13 […]